A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer.
Dongling ZouMingfang GuoQi ZhouPublished in: BMC cancer (2021)
ClinicalTrials.gov , NCT04542356 . Registered 9 September 2020 - Retrospectively registered.